SK Bioscience’s shares are up about 262% since they started trading in Seoul in the first quarter.The IPO raised $1.3 billion for the firm, which is a local Covid-19 vaccine-production partner with As …
( read original story …)
The Shanghai News
SK Bioscience’s shares are up about 262% since they started trading in Seoul in the first quarter.The IPO raised $1.3 billion for the firm, which is a local Covid-19 vaccine-production partner with As …
( read original story …)